Recent progress in DNA methyltransferase inhibitors as anticancer agents

Z Zhang, G Wang, Y Li, D Lei, J Xiang… - Frontiers in …, 2022 - frontiersin.org
DNA methylation mediated by DNA methyltransferase is an important epigenetic process
that regulates gene expression in mammals, which plays a key role in silencing certain …

DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer

V Singh, P Sharma, N Capalash - Current cancer drug targets, 2013 - ingentaconnect.com
DNA methylation is an epigenetic modification involved in gene expression regulation. In
cancer, the DNA methylation pattern becomes aberrant, causing an array of tumor …

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

N Herold, SG Rudd, L Ljungblad, K Sanjiv… - Nature medicine, 2017 - nature.com
The cytostatic deoxycytidine analog cytarabine (ara-C) is the most active agent available
against acute myelogenous leukemia (AML). Together with anthracyclines, ara-C forms the …

Novel clofarabine-based combinations with polyphenols epigenetically reactivate retinoic acid receptor beta, inhibit cell growth, and induce apoptosis of breast cancer …

K Lubecka, A Kaufman-Szymczyk… - International journal of …, 2018 - mdpi.com
An epigenetic component, especially aberrant DNA methylation pattern, has been shown to
be frequently involved in sporadic breast cancer development. A growing body of literature …

Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: a retrospective cohort study

J Xu, TT Lv, XF Zhou, Y Huang, DD Liu, GL Yuan - Medicine, 2018 - journals.lww.com
Efficacy of common salvage chemotherapy regimens in patients... : Medicine Efficacy of
common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid …

[HTML][HTML] The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia

DJPM Stumpel, P Schneider, R Pieters… - European Journal of …, 2015 - Elsevier
MLL-rearranged acute lymphoblastic leukaemia (ALL) in infants is the most difficult-to-treat
type of childhood ALL, displaying a chemotherapy-resistant phenotype, and unique histone …

Identification of 3-(9H-carbazol-9-yl)-2-(1, 3-dioxoisoindolin-2-yl) propanoic acids as promising DNMT1 inhibitors

J Liu, M Ruan, Y Liu, X Hong, L Zhang… - European Journal of …, 2024 - Elsevier
Abstract DNA methyltransferase 1 (DNMT1) is the primary enzyme responsible for
maintaining DNA methylation patterns during cellular division, crucial for cancer …

Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase …

A KAuFMAN‑SzyMCzyK, K Majda… - Molecular …, 2019 - spandidos-publications.com
Abstract Clofarabine (2‑chloro‑2'‑fluoro‑2'‑deoxyarabinosyladenine, CIF), a second‑
generation 2'‑deoxyadenosine analog, possesses a variety of anti‑cancer activities …

Clofarabine in pediatric acute leukemia: current findings and issues

N Hijiya, E Barry, RJ Arceci - Pediatric blood & cancer, 2012 - Wiley Online Library
Clofarabine is a second‐generation purine nucleoside analog and has significant anti‐
leukemic activity as a single agent. It is approved by the United States Food and Drug …

Clofarabine: Structure, mechanism of action, and clinical pharmacology

WB Parker, V Gandhi - Chemotherapy for Leukemia: Novel Drugs and …, 2017 - Springer
Similar to fludarabine and cladribine, clofarabine (2-chloro-2′-fluoro-2′-
deoxyarabinosyladenine) is resistant to deamination by adenosine deaminase due to the …